seqüências geneticamente modificadas de antígenos de plasmodium vivax, composições vacinais contendo proteínas recombinantes e vírus recombinantes que expressam esses antígenos e método de vacinação dose-reforço contra malária
The present invention relates to the construction of modified genetic sequences, which comprise sequences for antigens (DBP-PA, DBP-AM, DBP-MT, AMA-1, CS and MSP-1 ) of Plasmodium vivax, the corresponding recombinant proteins encoded by said sequences as well as genetically modified viruses that exp...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | por |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to the construction of modified genetic sequences, which comprise sequences for antigens (DBP-PA, DBP-AM, DBP-MT, AMA-1, CS and MSP-1 ) of Plasmodium vivax, the corresponding recombinant proteins encoded by said sequences as well as genetically modified viruses that express these recombinant antigens. In addition, the present invention refers to a method of prime-boost vaccination using adenoviral or poxviral vectors, purified proteins for immunization of mammals and vaccine compositions to be used as vaccines against malaria. |
---|